Frost edit · Free shipping over $70 · Cool essentials

Login Register

semaglutide antibody Biosimilar, Research Grade Human Semaglutide Neutralizing Antibody ELISA

semaglutide antibody

semaglutide antibody Biosimilar, Research Grade Human Semaglutide Neutralizing Antibody ELISA

SKU: 81076223012

4.5

USD29.32 USD55.32

Pay in 4 interest-free payments of $7.33 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 13 - Aug 18

Description

Sold exclusively to qualified research professionals and institutions

semaglutide antibody Biosimilar, Research Grade Human Semaglutide Neutralizing Antibody ELISA

Two proven GLP-1 options one simple program

semaglutide antibody Biosimilar, Research Grade Human Semaglutide Neutralizing Antibody ELISA

As with many areas of medicine, more research is needed to fully understand the connection between GLP-1s and sleep

semaglutide antibody Biosimilar, Research Grade Human Semaglutide Neutralizing Antibody ELISA

The FDA resolved the semaglutide shortage in late 2024 and the tirzepatide shortage in early 2025, narrowing but not closing the legitimate window

semaglutide antibody Biosimilar, Research Grade Human Semaglutide Neutralizing Antibody ELISA

Exchange/Return Notes

We offer a 30-day return/exchange service after receiving.
Final sale items are not eligible for returns or exchanges.
To process your return/exchange, please contact us at [email protected]
Please click here for more details>>> Return & Exchange Policy

You may also like

FDA approval for Zepbound (tirzepatide) injection, the first and only obesity treatment of its kind that activates both GIP and GLP-1 hormone receptors - Eli Lilly

FDA approval for Zepbound (tirzepatide) injection, the first and only obesity treatment of its kind that activates both GIP and GLP-1 hormone receptors - Eli Lilly

US$ 24.36

4.5 (28 reviews)

Friendly Reminder 💡 The only FDA‑approved U.S. brands of tirzepatide are Mounjaro and Zepbound. All tirzepatide available locally in the Philippines comes from the grey market. Even if tested in U.S. labs

Friendly Reminder 💡 The only FDA‑approved U.S. brands of tirzepatide are Mounjaro and Zepbound. All tirzepatide available locally in the Philippines comes from the grey market. Even if tested in U.S. labs

US$ 26.32

4.9 (17 reviews)

FDA confirms tirzepatide shortage is still over, gives compounders a grace period

FDA confirms tirzepatide shortage is still over, gives compounders a grace period

US$ 27.11

5.0 (11 reviews)

FDA says shortage of GLP-1 drug tirzepatide is over

FDA says shortage of GLP-1 drug tirzepatide is over

US$ 23.18

5.0 (9 reviews)

Big update in pediatric diabetes care 🩺 Mounjaro® (tirzepatide) is now FDA-approved for children ≥10 years old with Type 2 diabetes as an adjunct to diet and exercise. What this means ⬇️

Big update in pediatric diabetes care 🩺 Mounjaro® (tirzepatide) is now FDA-approved for children ≥10 years old with Type 2 diabetes as an adjunct to diet and exercise. What this means ⬇️

US$ 24.20

4.6 (20 reviews)

FDA approves weight-loss drug Zepbound to treat sleep apnea

FDA approves weight-loss drug Zepbound to treat sleep apnea

US$ 28.00

4.9 (23 reviews)

FDA Approves Most Potent Weight Loss Drug Yet

FDA Approves Most Potent Weight Loss Drug Yet

US$ 28.75

4.8 (7 reviews)

FDA Says Compounded Tirzepatide Must Exit the Market

FDA Says Compounded Tirzepatide Must Exit the Market

US$ 26.52

4.7 (20 reviews)

Zepbound®

Zepbound®

US$ 28.07

4.6 (8 reviews)

Republican Administration Maintains Exclusivity Stance in GLP-1 (Tirzepatide) Compounding Dispute

Republican Administration Maintains Exclusivity Stance in GLP-1 (Tirzepatide) Compounding Dispute

US$ 25.21

4.8 (15 reviews)

Eli Lilly Gets FDA Approval for Zepbound for Certain Sleep Apnea Patients

Eli Lilly Gets FDA Approval for Zepbound for Certain Sleep Apnea Patients

US$ 24.99

4.8 (23 reviews)

November 21st is a court date for the compounders and the FDA to talk to the judge : r/tirzepatidecompound

November 21st is a court date for the compounders and the FDA to talk to the judge : r/tirzepatidecompound

US$ 25.52

4.7 (21 reviews)

fda tirzepatide november 21 FDA approves tirzepatide, Eli Lilly's new type 2 diabetes drug, and the company shares an estimated price

fda tirzepatide november 21 FDA approves tirzepatide, Eli Lilly's new type 2 diabetes drug, and the company shares an estimated price

US$ 21.05

4.6 (20 reviews)

Yesterday, the FDA announced approval for Zepbound™ for weight management. Tirzepatide, the active ingredient in Zepbound™, is already approved under the trade name Mounjaro™ to be used along with diet and exercise

Yesterday, the FDA announced approval for Zepbound™ for weight management. Tirzepatide, the active ingredient in Zepbound™, is already approved under the trade name Mounjaro™ to be used along with diet and exercise

US$ 25.08

5.0 (18 reviews)

FDA Drug Recalls and Warnings: Illegal GLP-1 Sales and Misleading Marketing by Novo Nordisk and Eli Lilly

FDA Drug Recalls and Warnings: Illegal GLP-1 Sales and Misleading Marketing by Novo Nordisk and Eli Lilly

US$ 29.35

4.7 (26 reviews)

Retatrutide vs Zepbound: Which Is Better?

Retatrutide vs Zepbound: Which Is Better?

US$ 29.50

5.0 (24 reviews)

What Is Tirzepatide Used for? Approved and Potential Uses

What Is Tirzepatide Used for? Approved and Potential Uses

US$ 24.06

4.5 (6 reviews)

Will FDA shut down compounded tirzepatide?

Will FDA shut down compounded tirzepatide?

US$ 21.12

4.5 (30 reviews)

FDA Approves Diabetes Drug Tirzepatide for Chronic Weight Management

FDA Approves Diabetes Drug Tirzepatide for Chronic Weight Management

US$ 26.45

4.3 (13 reviews)

FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders

FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders

US$ 24.57

4.6 (20 reviews)